Literature DB >> 11834891

Alteration of M(3) subtype muscarinic receptors in the diabetic rat urinary bladder.

Yat-Ching Tong1, Juei-Tang Cheng.   

Abstract

The M(3) receptor (M(3)-mAChR) is the major muscarinic subtype in the animal bladder responsible for detrusor contraction. The alterations in its protein quantity and biosynthesis during diabetic cystopathy were investigated. 3-month-old male Wistar rats were divided into two groups: (1) 2-week diabetic rats and (2) normoglycemic control rats. Diabetes was induced by a single intravenous injection of 60 mg/kg streptozotocin. The amount of M(3) receptor protein in the rat bladder body tissue was measured by Western immunoblotting using monoclonal antibodies. For determination of M(3) muscarinic receptor mRNA in the bladder tissue, the method of Northern blotting was employed. The results of the Western immunoblotting showed that the amount of M(3)-mAChR protein in the diabetic bladder was significantly increased by about 70.2 +/- 8.5% when compared to the control bladder (p < 0.05, n = 8). Northern blotting demonstrated a 54.7 +/- 6.0% increase of M(3)-mAChR mRNA in the diabetic bladder (p < 0.05, n = 8). The findings of the present study demonstrated an upregulation of M(3)-mAChR biosynthesis in the diabetic urinary bladder. This phenomenon offers an explanation of the increased contractility after muscarinic stimulation of the detrusor muscle of diabetic animals. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834891     DOI: 10.1159/000056164

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  10 in total

1.  Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.

Authors:  Yi Wang; Gary G Deng; Kelvin P Davies
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-28       Impact factor: 4.310

2.  Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.

Authors:  K J Pak; R S Ostrom; M Matsui; F J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

Review 3.  Diabetic bladder dysfunction.

Authors:  Guiming Liu; Firouz Daneshgari
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

Review 4.  Big-conductance Ca2+-activated K+ channels in physiological and pathophysiological urinary bladder smooth muscle cells.

Authors:  Shankar P Parajuli; Yun-Min Zheng; Robert Levin; Yong-Xiao Wang
Journal:  Channels (Austin)       Date:  2016-04-21       Impact factor: 2.581

5.  Detrusor contractility to parasympathetic mediators is differentially altered in the compensated and decompensated states of diabetic bladder dysfunction.

Authors:  Nicole S Klee; Robert S Moreland; Derek M Kendig
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

6.  The intracellular pathway of the acetylcholine-induced contraction in cat detrusor muscle cells.

Authors:  J Y An; H S Yun; Y P Lee; S J Yang; J O Shim; J H Jeong; C Y Shin; J H Kim; D S Kim; U D Sohn
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

7.  Human amniotic fluid stem cell therapy can help regain bladder function in type 2 diabetic rats.

Authors:  Ching-Chung Liang; Steven W Shaw; Yung-Hsin Huang; Tsong-Hai Lee
Journal:  World J Stem Cells       Date:  2022-05-26       Impact factor: 5.247

8.  [The patient with diabetes in urologic practice: a special risk for lower urinary tract symptoms? Results of the Witten diabetes survey of 4071 type 2 diabetics].

Authors:  A Wiedemann; I Füsgen
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

9.  Improvement in bladder dysfunction after bladder transplantation of amniotic fluid stem cells in diabetic rats.

Authors:  Ching-Chung Liang; Sheng-Wen Steven Shaw; Yung-Hsin Huang; Yi-Hao Lin; Tsong-Hai Lee
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

Review 10.  The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A.

Authors:  Chung-Cheng Wang; Yung-Hong Jiang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2020-03-16       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.